Global Virtual Clinical Trials Market Size, Share, and COVID-19 Impact Analysis, By Study Design (Interventional, Observational, and Expanded Access), By Indication (Oncology and Cardiovascular Disease), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033.

Industry: Healthcare

RELEASE DATE May 2025
REPORT ID SI10077
PAGES 190
REPORT FORMAT PathSoft

  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis By Study Design
      2. Market Attractiveness Analysis By Indication
      3. Market Attractiveness Analysis By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Provides convenience to the patients in monitoring their health status which makes a large number of patients go for such devices
    3. Restraints
      1.  There is a difference in the regulatorily norms between regions for the acceptance and conductance of virtual mode of clinical trials
    4. Opportunities
      1.  Enhances patient recruitment by analyzing health records
    5. Challenges
      1. May delay trial approvals and increase compliance costs.
  6. Global Virtual Clinical Trials Market Analysis and Projection, By Study Design
    1. Segment Overview
    2. Interventional
    3. Observational
    4. Expanded Access
  7. Global Virtual Clinical Trials Market Analysis and Projection, By Indication
    1. Segment Overview
    2. Oncology
    3. Cardiovascular Disease
  8. Global Virtual Clinical Trials Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  9. Global Virtual Clinical Trials Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Virtual Clinical Trials Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  10. Company Profiles
    1. ICON, plc
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2.   Parexel International Corporation 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  IQVIA 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4.   Covance 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.   PRA Health Sciences 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6.  LEO Innovation Lab
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7.   Medidata
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. Oracle
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9.  CRF Health
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  Clinical Ink 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11.  Medable, Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    12.   Halo Health Systems
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    13.  Croprime 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    14.  Others
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

 

List of Table

  1. Global Virtual Clinical Trials Market, By Study Design, 2024-2034(USD Billion)
  2. Global Interventional, Virtual Clinical Trials Market, By Region, 2024-2034(USD Billion)
  3. Global Observational, Virtual Clinical Trials Market, By Region, 2024-2034(USD Billion)
  4. Global Expanded Access, Virtual Clinical Trials Market, By Region, 2024-2034(USD Billion)
  5. Global Virtual Clinical Trials Market, By Indication, 2024-2034(USD Billion)
  6. Global Oncology, Virtual Clinical Trials Market, By Region, 2024-2034(USD Billion)
  7. Global Cardiovascular Disease, Virtual Clinical Trials Market, By Region, 2024-2034(USD Billion)
  8. North America Virtual Clinical Trials Market, By Study Design, 2024-2034(USD Billion)
  9. North America Virtual Clinical Trials Market, By Indication, 2024-2034(USD Billion)
  10. U.S.  Virtual Clinical Trials Market, By Study Design, 2024-2034(USD Billion)
  11. U.S.  Virtual Clinical Trials Market, By Indication, 2024-2034(USD Billion)
  12. Canada Virtual Clinical Trials Market, By Study Design, 2024-2034(USD Billion)
  13. Canada Virtual Clinical Trials Market, By Indication, 2024-2034(USD Billion)
  14. Mexico Virtual Clinical Trials Market, By Study Design, 2024-2034(USD Billion)
  15. Mexico Virtual Clinical Trials Market, By Indication, 2024-2034(USD Billion)
  16. Europe Virtual Clinical Trials Market, By Study Design, 2024-2034(USD Billion)
  17. Europe Virtual Clinical Trials Market, By Indication, 2024-2034(USD Billion)
  18. Germany Virtual Clinical Trials Market, By Study Design, 2024-2034(USD Billion)
  19. Germany Virtual Clinical Trials Market, By Indication, 2024-2034(USD Billion)
  20. France Virtual Clinical Trials Market, By Study Design, 2024-2034(USD Billion)
  21. France Virtual Clinical Trials Market, By Indication, 2024-2034(USD Billion)
  22. U.K.  Virtual Clinical Trials Market, By Study Design, 2024-2034(USD Billion)
  23. U.K.  Virtual Clinical Trials Market, By Indication, 2024-2034(USD Billion)
  24. Italy Virtual Clinical Trials Market, By Study Design, 2024-2034(USD Billion)
  25. Italy Virtual Clinical Trials Market, By Indication, 2024-2034(USD Billion)
  26. Spain Virtual Clinical Trials Market, By Study Design, 2024-2034(USD Billion)
  27. Spain Virtual Clinical Trials Market, By Indication, 2024-2034(USD Billion)
  28. Asia Pacific Virtual Clinical Trials Market, By Study Design, 2024-2034(USD Billion)
  29. Asia Pacific Virtual Clinical Trials Market, By Indication, 2024-2034(USD Billion)
  30. Japan Virtual Clinical Trials Market, By Study Design, 2024-2034(USD Billion)
  31. Japan Virtual Clinical Trials Market, By Indication, 2024-2034(USD Billion)
  32. China Virtual Clinical Trials Market, By Study Design, 2024-2034(USD Billion)
  33. China Virtual Clinical Trials Market, By Indication, 2024-2034(USD Billion)
  34. India Virtual Clinical Trials Market, By Study Design, 2024-2034(USD Billion)
  35. India Virtual Clinical Trials Market, By Indication, 2024-2034(USD Billion)
  36. South America Virtual Clinical Trials Market, By Study Design, 2024-2034(USD Billion)
  37. South America Virtual Clinical Trials Market, By Indication, 2024-2034(USD Billion)
  38. Brazil Virtual Clinical Trials Market, By Study Design, 2024-2034(USD Billion)
  39. Brazil Virtual Clinical Trials Market, By Indication, 2024-2034(USD Billion)
  40. The Middle East and Africa Virtual Clinical Trials Market, By Study Design, 2024-2034(USD   Billion)
  41. The Middle East and Africa Virtual Clinical Trials Market, By Indication, 2024-2034(USD   Billion)
  42. UAE Virtual Clinical Trials Market, By Study Design, 2024-2034(USD Billion)
  43. UAE Virtual Clinical Trials Market, By Indication, 2024-2034(USD Billion)
  44. South Africa Virtual Clinical Trials Market, By Study Design, 2024-2034(USD Billion)
  45. South Africa Virtual Clinical Trials Market, By Indication, 2024-2034(USD Billion)

List of Figures 

  1. Global Virtual Clinical Trials Market Segmentation
  2. Virtual Clinical Trials Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Virtual Clinical Trials Market
  9. Top Winning Strategies, 2024-2034
  10. Top Winning Strategies, By Development, 2024-2034(%)
  11. Top Winning Strategies, By Company, 2024-2034
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2024
  18. Market Share Analysis, 2024
  19. Restraint and Drivers:  Virtual Clinical Trials Market
  20. Virtual Clinical Trials Market Segmentation, By Study Design
  21. Virtual Clinical Trials Market For Interventional, By Region, 2024-2034 ($ Billion)
  22.  Virtual Clinical Trials Market For Observational, By Region, 2024-2034 ($ Billion)
  23. Virtual Clinical Trials Market For Expanded Access, By Region, 2024-2034 ($ Billion)
  24.  Virtual Clinical Trials Market Segmentation, By Indication
  25.  Virtual Clinical Trials Market For Oncology, By Region, 2024-2034 ($ Billion)
  26.  Virtual Clinical Trials Market For Cardiovascular Disease, By Region, 2024-2034 ($ Billion)
  27. ICON, plc: Net Sales, 2024-2034 ($ Billion)
  28. ICON, plc: Revenue Share, By Segment, 2024 (%)
  29. ICON, plc: Revenue Share, By Region, 2024 (%)
  30. Parexel International Corporation: Net Sales, 2024-2034 ($ Billion)
  31. Parexel International Corporation: Revenue Share, By Segment, 2024 (%)
  32. Parexel International Corporation: Revenue Share, By Region, 2024 (%)
  33. IQVIA: Net Sales, 2024-2034 ($ Billion)
  34. IQVIA: Revenue Share, By Segment, 2024 (%)
  35. IQVIA: Revenue Share, By Region, 2024 (%)
  36. Covance: Net Sales, 2024-2034 ($ Billion)
  37. Covance: Revenue Share, By Segment, 2024 (%)
  38. Covance: Revenue Share, By Region, 2024 (%)
  39. PRA Health Sciences: Net Sales, 2024-2034 ($ Billion)
  40. PRA Health Sciences: Revenue Share, By Segment, 2024 (%)
  41. PRA Health Sciences: Revenue Share, By Region, 2024 (%)
  42. LEO Innovation Lab: Net Sales, 2024-2034 ($ Billion)
  43. LEO Innovation Lab: Revenue Share, By Segment, 2024 (%)
  44. LEO Innovation Lab: Revenue Share, By Region, 2024 (%)
  45. Medidata: Net Sales, 2024-2034 ($ Billion)
  46. Medidata: Revenue Share, By Segment, 2024 (%)
  47. Medidata: Revenue Share, By Region, 2024 (%)
  48. Oracle: Net Sales, 2024-2034 ($ Billion)
  49. Oracle: Revenue Share, By Segment, 2024 (%)
  50. Oracle: Revenue Share, By Region, 2024 (%)
  51. CRF Health.: Net Sales, 2024-2034 ($ Billion)
  52. CRF Health.: Revenue Share, By Segment, 2024 (%)
  53. CRF Health.: Revenue Share, By Region, 2024 (%)
  54. Clinical Ink: Net Sales, 2024-2034 ($ Billion)
  55. Clinical Ink: Revenue Share, By Segment, 2024 (%)
  56. Clinical Ink: Revenue Share, By Region, 2024 (%)
  57. Medable, Inc.: Net Sales, 2024-2034 ($ Billion)
  58. Medable, Inc.: Revenue Share, By Segment, 2024 (%)
  59. Medable, Inc.: Revenue Share, By Region, 2024 (%)
  60. Halo Health Systems: Net Sales, 2024-2034 ($ Billion)
  61. Halo Health Systems: Revenue Share, By Segment, 2024 (%)
  62. Halo Health Systems: Revenue Share, By Region, 2024 (%)
  63. Croprime: Net Sales, 2024-2034 ($ Billion)
  64. Croprime: Revenue Share, By Segment, 2024 (%)
  65. Croprime: Revenue Share, By Region, 2024 (%)
  66. Others: Net Sales, 2024-2034 ($ Billion)
  67. Others: Revenue Share, By Segment, 2024 (%)
  68. Others: Revenue Share, By Region, 2024 (%)

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies